James Smith- pharma
- October 29, 2026
- 22 views
James SmithAnti Cancer Drugs: The Real Impact of Price Cuts Revealed
Anti cancer drugs are under scrutiny as public health campaigners question the Centre’s recent price cuts.
- James Smith
- pharma
- October 26, 2026
- 16 views
Stroke-prevention drug: Safe New Class with Proven Benefits
Stroke-prevention drug approval in China marks a global first for Bayer, offering new hope in treatment.
- James Smith
- pharma
- October 21, 2026
- 21 views
Hepatitis B Approval: Proven Cure Strategy Gains Focus
Hepatitis B Approval highlights GSK’s innovative approach to treatment.
- James Smith
- pharma
- October 18, 2026
- 22 views
Anuh Pharma Tarapur Plant: Proven Boost for API Capacity
Anuh Pharma Tarapur Plant acquisition boosts API capacity significantly. Discover the details behind this strategic move.
- James Smith
- pharma
- October 14, 2026
- 24 views
FDA Approval Pill: Worth a Proven $400M+ Opportunity
FDA approval pill could revolutionize treatment and is projected to generate over $400 million in revenue.
- James Smith
- pharma
- October 9, 2026
- 58 views
Cancer Drug Prices: Clear Path to 70% Savings Ahead
Cancer drug prices could see a significant drop of up to 70% due to government action.
- James Smith
- pharma
- October 7, 2026
- 32 views
Medexus Specialty Drug Launches: A Smart Move for Growth
Medexus specialty drug launches are gaining attention for their potential impact on the market.
- James Smith
- pharma
- October 1, 2026
- 31 views
Sudarshan Chemical’s acquisition is a Smart Move for Growth
Sudarshan Chemical acquisition marks a significant investment in Sudarshan Colorants, enhancing market presence and potential.
- James Smith
- pharma
- September 29, 2026
- 42 views
FDA Approval Bone Drug: Teva’s Proven New Treatment
FDA approval bone drug marks a significant advancement in treatment options.
- James Smith
- pharma
- September 24, 2026
- 44 views
Generic Zofran Launch: A Smart Move for Oncology Care
Generic Zofran launch expands oncology supportive care options in Canada.
